Ospedale Santa Chiara Azienda Sanitaria Universitaria Integrata del Trentino

Trento 38122

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-resistant Prostate Cancer

Studies at this site

• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer — Recruiting now
• Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute) — Running, not enrolling